Primco Management announces acquisition of 51% interest in Pops Edibles

Primco Management Inc. (OTCBB: PMCM), a medical marijuana, real estate management and multi-media company today announced that the Company has acquired a 51% interest in Pops Edibles, a San Francisco bay area based medical marijuana boutique that specializes in the formulation and manufacture of both Tetrahydrocannabinol ("THC") and Cannabidiol ("CBD") based 100% organic lollipops designed for both the medical and recreational communities.

"The acquisition of Pops Edibles ( www.popsedibles.com ) allows us to immediately enter the edibles market with a superior organic product that can be distributed throughout the Pacific region," stated David Michery, CEO. "We look forward to bringing Mel Kurland and her team to Seattle to set up a manufacturing facility in one of our producer/processing operations."

"We are very excited to have this opportunity to work with Primco," stated Melissa Kurland, President of Pops Edibles. "Our company is unique in that we produce a 100% organic product that is tested for efficacy and potency. Our products come in both CBD and THC strains, offering medical patients the options that they require, and the recreational customer, the performance they expect. We look forward to working closely with Primco to develop several new and innovative products while remaining committed to providing our customers with some of the highest quality and naturally produced edibles in the Western U.S."

Source:

Primco Management Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.